|

Soutschek, E., Krämer, B., Wassenberg, D., Hechtfischer, A.
MIKROGEN GmbH, Fraunhoferstr. 20, 82152 Martinsried
E-mail: soutschek@mikrogen.de
The use of recombinant Borrelia antigens in standardized test
systems like ELISA (recomWell) and Westernblot (recomBlot) is well
documented. The immunodominant antigens p100/p83, p58, p41, p39, OspA,
OspC, Osp17/p18, internal flagellin fragments or VLSE are well
characterized and can be used in serological applications. Beside choosing
the right antigen combination, assay procedure (e. g. stringency of
buffers, incubation time) and test interpretation are decisive for high
specificity and sensitivity.
One major drawback of conventional assay procedures based on bacterial
lysates of selected strains is the variable gene expression and the lack
of standardization therefore. Also the heterogenous immune response
against different Borrelia burgdorferi subtypes remains unsolved.
The sequence variability of the outer surface proteins like OspA and OspC
is the main cause for this finding. Aim of this investigation was to
produce by genetechnological means immunodominant antigens of different Borrelia
genospecies and serotypes and test them with clinically defined patient
sera. In particular OspC antigens of seven Borrelia garinii strains
(PBr, PTrob, PBi, PHei, TN, T25, 20047) and one representative strain each
of Borrelia afzelii (PKo) and Borrelia burgdorferi sensu stricto
(B31) were serologically characterized. Sera of Lyme Borreliosis patients,
especially of patients with neuroborreliosis, often react only with
antigens of one selected Borrelia garinii strain. It is notable
that the IgG response is more strain specific than the IgM response. The
results of these investigations finally lead to an improved combination of
recombinant Borrelia antigens from several genospecies for serodiagnosis.
By improving the sensitivity of serological testing the reduction of
possibly false negative assay results is most important for the patients.
[ POWERPOINT
PRESENTATION ]
|
Feedback And Comments
|
Please enter a comment or feedback.
|
|
|
CRTBI - Extended Abstracts
Bunikis J et al.: Structure and Function of the Surface Proteins of Borrelia Spirochetes
Dambrauskienè V et al.: Epidemiology of Tick-Born Encephalitis and it's Clinical Manifestations in
Panevèzys City County
Egenvall A et al.: A serosurvey of granulocytic Ehrlicha spp. and Borrelia burgdorferi sensu lato
in 2018 Swedish horses
Gray J S et al.: The biology of Ixodes ticks, with special reference to Ixodes ricinus
Guillaume B et al.: Human Granulocytic Ehrlichia Infection in Belgium
Haglund M et al.: Tick-borne encephalitis (TBE) - an overview
Larsen K et al.: Tick species and arthropod-transmitted infections from Danish cats and dogs
Lundkvist Å et al.: Characterization of Tick-borne enchephalitis virus from Latvia – evidence for co-circulation of three distinct subtypes
Malmgren L et al.: A field trial of the effectiveness of 65% permetrin spot-on and 9.7% fipronil spot-on against ticks (Ixodes ricinus) on dogs
Massung R F et al.: Genetic Variants of Ehrlichia phagocytophila in the United States
Nilsson I et al.: Serological evidence of Lyme arthritis in Egypt
Nyman D et al.: Ticks have preferences in choosing human hosts
Ornstein K et al.: Quantification of spirochete burden in Borrelia burgdorferi infected ticks fed on OspA immunized mice by 16S rRNA RT real-time PCR
Randolph S et al.: Epidemiological consequences of tick ecology
Skarpaas T et al.: Tick-borne encephalitis in Norway
Soutschek E et al.: A defined mixture of recombinant antigens from several Borrelia genospecies improves serodiagnosis of Lyme disease
von Stedingk L V et al.: Recent research on human babesiosis – the Scandinavian perspective
Stuen S et al.: Granulocytic Ehrlichia infection in domestic and wild ruminants in Norway
Widhe M et al.: Cytokines in Lyme Borreliosis: in vivo levels of TGF-b1, TNF-a and IL-6 in serum and cerebrospinal fluid from patients with neuroborreliosis or erythema migrans in relation to clinical outcome |